Skip to main content
. 2019 Dec 18;26(5):341–350. doi: 10.1177/1753425919895086

Figure 4.

Figure 4.

(a) Relationship between serum CXCL12 levels and VAS among IDD patients. (b) Relationship between serum CXCL12 levels and ODI among IDD patients. (c) Comparison of serum CXCL12 levels between IDD patients with leg pain and IDD patients without leg pain.